238 related articles for article (PubMed ID: 11889405)
1. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
3. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
5. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
6. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
8. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of poorly-differentiated squamous cell carcinoma of the nasopharynx.
Mitsuhashi N; Niibe H; Hayakawa K; Tamaki Y; Takahashi M; Yamakawa M; Hashida I; Akimoto T; Kiryu Y
Jpn J Clin Oncol; 1994 Aug; 24(4):191-8. PubMed ID: 8072197
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
Zhang Y; Huang D; Yu G
Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
[TBL] [Abstract][Full Text] [Related]
14. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.
Kwong DL; Wei WI; Cheng AC; Choy DT; Lo AT; Wu PM; Sham JS
Cancer; 2001 Mar; 91(6):1105-13. PubMed ID: 11267955
[TBL] [Abstract][Full Text] [Related]
15. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy].
Zhu S; Zhai F; Yin W
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):129-31. PubMed ID: 10920963
[TBL] [Abstract][Full Text] [Related]
17. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]